Philip Frost M.d., Ph.d.

Biography

Dr. Philip Frost, also known as Phil, M.D., Ph.D., has been Chief Executive Officer of Opko Health, Inc. since March 27, 2007. Dr. Frost serves as the Managing Director and General Partner of Frost Phillip MD Et Al. He serves as General Partner at Frost Group, LLC, Frost Group LLC and Incentive 2 Management Inc. (Alternate Name: Incentive Management Inc.). He also serves as Chief Executive Officer of Opko Health Inc. at Claros Diagnostics, Inc. He served as a Special Advisor of Castle Brands Inc. He served as a General Partner of Peregrine Ventures. He served as the Chief Executive Officer of eXegenics Inc. He served as Chief Executive Officer from 1987 to January 26, 2006 and also served as its President from July 1991 to January 1995 at IVAX LLC. He served as Lieutenant Commander in the U.S. Public Health Service at the National Cancer Institute, in Bethesda, Maryland from 1963 to 1965. He served as Chief Executive Officer at Teva Pharmaceutical Industries in 1987. He has been the Chairman of Opko Health, Inc. since March 27, 2007. He has been the Chairman of OPKO Biologics since March 2008. He serves as the Chairman of the Board of Non-Invasive Monitoring Systems Inc. He serves as the Chairman of Temple Emanu El. He serves as the Chairman of Medical Advisory Board of Daxor Corporation. He has been the Chairman of Strategic Advisory Board and Member of Strategic Advisory Board at Drone Aviation Holding Corp. since August 28, 2014. He serves as the Chairman of University of Miami. Mr. Phillip Frost is a Co-Owner at Frost Gamma Investments Trust. He has been the Vice Chairman of Cogint, Inc. since December 2015 and has been its Director since December 8, 2015. He serves as Vice Chairman at IDI, Inc. He has been a Director of Cocrystal Pharma, Inc. since January 2, 2014 and OPKO Biologics since May 2007. He serves as a Director at Non-Invasive Monitoring Systems Inc. He has been a Senior Trustee of University of Miami since 1983. He serves as a Member of Advisory Board at Non-Invasive Monitoring Systems Inc. He serves as a Director of Fabrus, Inc., and The Center for Blood Research Inc., an affiliate of the Harvard Medical School. He has been a Director of IDI, Inc. since December 8, 2015, Opko Health, Inc. since March 27, 2007 and Independent Director of Sevion Therapeutics, Inc. (formerly Senesco Technologies, Inc.) since May 2014. He serves as a Governor of Tel Aviv University. He also serves as a Member of the Florida Council of 100. He serves as a Trustee of each of the Scripps Research Institutes, the Miami Jewish Home for the Aged and the Mount Sinai Medical Center. He has been a Director of Ladenburg Thalmann Financial Services Inc., since March 2004. He has been a Director of Castle Brands Inc. since October 2008. He serves as Chairman and Director at Claros Diagnostics, Inc. He served as the Chairman and Director of Ideation Acquisition Corp. from June 1, 2007 to October 30, 2009, ERBA Diagnostics, Inc. from March 2001 to April 2006, IVAX Corporation since 1987 and Key Pharmaceutical Inc., from 1972 to 1986. He served as a Director at Protalix BioTherapeutics, Inc. ( Ladenburg Thalmann Financial Services Inc. from Dec 31, 2006 to Dec, 2007. He served as the Chairman and Director of Whitman Education Group, Inc. from 1992 to 2003. Dr. Frost served as the Chairman of Key Pharmaceuticals, Inc. from 1972 to 1986. He served as the Chairman and Director of IVAX Diagnostics Inc. He served as the Chairman of Teva Pharmaceutical Industries Limited from March 2010 to December 31, 2014. He served as an Executive Vice Chairman and Director at Tiger Media, Inc. since December 9, 2015. He served as Vice Chairman of Teva Pharmaceutical Industries Limited from January 2006 to March 2010. He served as a Co-Vice Chairman of NYSE MKT LLC since April 2005 and served as its Governor. He served as a Co-Vice Chairman of American Stock Exchange LLC from April 2005 to 2008 and its Governor from 1992 to 2008. He served as the Chairman of the Board of Continucare Corporation from September 1996 to April 2002, Pan Am Corporation since April 16, 1996 and North American Vaccine from December 1990 to 2000. He served as a Director from May 2001 to July 2002 at Ladenburg Thalmann Financial Services Inc. He served as Director from September 2005 to September 12, 2007 at Castle Brands Inc. He served as a Member of Scientific Advisory Board at MusclePharm Corporation. He served as an Independent Director of Continucare Corporation since January 2004. He served as a Director of PROLOR Biotech, Inc. since May 2007. He served as a Director of North American Vaccine since October 1989, ERBA Diagnostics, Inc., from 2001 to April 2006, Orthodontix Inc., since January 03, 2007, Cellular Technical Services Co. Inc. since April 12, 2005 and Protalix BioTherapeutics, Inc., from December 31, 2006 to December 2007. He served as a Director of Teva Pharmaceutical Industries Limited from 2006 to February 4, 2015. He served as a Director of American Exploration Company from 1983 to 1998 and Northrup Grumman Corporation from 1996 to May 20, 2009. He served as a Director of TransEnterix, Inc. since 2013. He served as a Member of Board of Regents of Smithsonian Institution from 2006 to 2010. He served as a Director of Teva Czech Industries s.r.o. He served as a Director of SafeStitch Medical, Inc., since 2005. He served as a Director of Northrop Grumman Corporation from 1996 to May 20, 2009, Pan Am Corporation since March 8, 1996 and IVAX LLC since 1987. He served as a Director of GBI Capital Management Corp., IVAX-CR AS and IVAX Pharmaceuticals s.r.o. He served as a Director of CoCrystal Discovery, Inc. He served as the Chairman of the Department of Dermatology at Mt. Sinai Medical Center of Greater Miami, Miami Beach, Florida from 1972 to 1990. He served as the Chairman of the Board at IVAX LLC from 1987 to January 26, 2006. His internship was conducted at the University of Chicago Hospitals and Clinics in Straight Medicine. He attended the University of Paris from 1995 to 1996. Dr. Frost received a B.A. in French Literature from the University of Pennsylvania in 1957 and Doctor of Medicine Degree from the Albert Einstein College of Medicine, New York in 1961.

Research Interest

Chemical Engineering & Process Technology